Nanobiotix S.A. (EPA: NANO)
France
· Delayed Price · Currency is EUR 4.984
+0.104 (2.13%)
Aug 30, 2024, 5:35 PM CET
Nanobiotix Income Statement
Financials in millions EUR. Fiscal year is April - March.
Millions EUR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Operating Revenue | 397.16 | 397.16 | 341.55 | 281.95 | 204.65 | 446.71 | Upgrade
|
| Other Revenue | 4.85 | 4.85 | - | - | - | - | Upgrade
|
| Revenue | 402.01 | 402.01 | 341.55 | 281.95 | 204.65 | 446.71 | Upgrade
|
| Revenue Growth (YoY) | 17.70% | 17.70% | 21.14% | 37.77% | -54.19% | 4.38% | Upgrade
|
| Cost of Revenue | 253.24 | 253.24 | 212.51 | 176.84 | 132.41 | 275.4 | Upgrade
|
| Gross Profit | 148.77 | 148.77 | 129.04 | 105.11 | 72.24 | 171.31 | Upgrade
|
| Selling, General & Admin | 93.58 | 93.58 | 88.57 | 73.16 | 69.08 | 104.25 | Upgrade
|
| Other Operating Expenses | 6.66 | 6.66 | -3.22 | 1.7 | 2.26 | 3.86 | Upgrade
|
| Operating Expenses | 146.64 | 146.64 | 127.06 | 126.5 | 118.19 | 132.66 | Upgrade
|
| Operating Income | 2.13 | 2.13 | 1.98 | -21.38 | -45.95 | 38.66 | Upgrade
|
| Interest Expense | -14.99 | -14.99 | -9.5 | -5.45 | -5.24 | -6.34 | Upgrade
|
| Interest & Investment Income | 0.81 | 0.81 | 1.66 | 1.6 | 1.98 | 0.22 | Upgrade
|
| Earnings From Equity Investments | 0.64 | 0.64 | -2.63 | -1.25 | -0.06 | -0.03 | Upgrade
|
| Currency Exchange Gain (Loss) | -6.71 | -6.71 | -8.9 | 2.82 | -1.55 | -16.26 | Upgrade
|
| Other Non Operating Income (Expenses) | -3.07 | -3.07 | 0.58 | -6.19 | 9.67 | -2.16 | Upgrade
|
| EBT Excluding Unusual Items | -21.19 | -21.19 | -16.81 | -29.85 | -41.15 | 14.09 | Upgrade
|
| Impairment of Goodwill | - | - | - | - | - | -0.51 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | -2.46 | -0.42 | Upgrade
|
| Asset Writedown | - | - | - | - | - | -23.9 | Upgrade
|
| Other Unusual Items | - | - | - | -12.23 | -15.66 | -42.82 | Upgrade
|
| Pretax Income | -21.19 | -21.19 | -16.81 | -42.08 | -59.27 | -53.55 | Upgrade
|
| Income Tax Expense | -8.97 | -8.97 | 1.29 | 1.05 | -2.1 | 1.96 | Upgrade
|
| Earnings From Continuing Operations | -12.22 | -12.22 | -18.09 | -43.13 | -57.17 | -55.51 | Upgrade
|
| Minority Interest in Earnings | -0.01 | -0.01 | 0.03 | 0.04 | 0.03 | 0.04 | Upgrade
|
| Net Income | -12.23 | -12.23 | -18.07 | -43.09 | -57.15 | -55.47 | Upgrade
|
| Net Income to Common | -12.23 | -12.23 | -18.07 | -43.09 | -57.15 | -55.47 | Upgrade
|
| Shares Outstanding (Basic) | 41 | 41 | 39 | 31 | 31 | 31 | Upgrade
|
| Shares Outstanding (Diluted) | 41 | 41 | 39 | 31 | 31 | 31 | Upgrade
|
| Shares Change (YoY) | 6.23% | 6.23% | 22.74% | -0.05% | 0.06% | -0.56% | Upgrade
|
| EPS (Basic) | -0.30 | -0.30 | -0.47 | -1.37 | -1.82 | -1.77 | Upgrade
|
| EPS (Diluted) | -0.30 | -0.30 | -0.47 | -1.37 | -1.82 | -1.77 | Upgrade
|
| Free Cash Flow | 20.79 | 20.79 | -18.61 | -1 | -44.21 | -0.85 | Upgrade
|
| Free Cash Flow Per Share | 0.51 | 0.51 | -0.48 | -0.03 | -1.41 | -0.03 | Upgrade
|
| Gross Margin | 37.01% | 37.01% | 37.78% | 37.28% | 35.30% | 38.35% | Upgrade
|
| Operating Margin | 0.53% | 0.53% | 0.58% | -7.58% | -22.45% | 8.65% | Upgrade
|
| Profit Margin | -3.04% | -3.04% | -5.29% | -15.28% | -27.92% | -12.42% | Upgrade
|
| Free Cash Flow Margin | 5.17% | 5.17% | -5.45% | -0.35% | -21.60% | -0.19% | Upgrade
|
| EBITDA | 51.13 | 51.13 | 56.72 | 28.93 | 0.76 | 58.83 | Upgrade
|
| EBITDA Margin | 12.72% | 12.72% | 16.61% | 10.26% | 0.37% | 13.17% | Upgrade
|
| D&A For EBITDA | 49 | 49 | 54.74 | 50.31 | 46.71 | 20.18 | Upgrade
|
| EBIT | 2.13 | 2.13 | 1.98 | -21.38 | -45.95 | 38.66 | Upgrade
|
| EBIT Margin | 0.53% | 0.53% | 0.58% | -7.58% | -22.45% | 8.65% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.